A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)
Clinical trial NCT02527096 · COMPLETED
Trial details
- NCT number
- NCT02527096
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-17
- Primary completion
- 2017-03-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.